| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/15/2011 | US7906645 Heterocyclic compounds as ccr2b antagonists |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906643 Methylene blue-curcumin analog for the treatment of Alzheimer's Disease |
| 03/15/2011 | US7906633 Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof |
| 03/15/2011 | US7906557 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether |
| 03/15/2011 | US7906556 Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| 03/15/2011 | US7906555 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| 03/15/2011 | US7906554 Combination chemotherapy compositions and methods |
| 03/15/2011 | US7906553 Substituted thiophene modulators of intracellular calcium |
| 03/15/2011 | US7906552 Compounds for prodrug for bonding, using prostaglandins |
| 03/15/2011 | US7906551 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors |
| 03/15/2011 | US7906550 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 03/15/2011 | US7906547 Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 03/15/2011 | US7906546 Tetrahydrocarbazoles and derivatives |
| 03/15/2011 | US7906545 Prodrugs of CC-1065 analogs |
| 03/15/2011 | US7906544 Inhibition of bacterial biofilms with imidazole derivatives |
| 03/15/2011 | US7906543 Method of reducing imiquimod impurity formation |
| 03/15/2011 | US7906542 Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
| 03/15/2011 | US7906541 Process to prepare new substituted 1H-benzo[d]imidazol-2(3H)-ones, new intermediates and their use as BACE 1 inhibitors |
| 03/15/2011 | US7906540 Antivirals for HIV and AIDS; compounds are 2-1,2,4-triazolin-5-ones, substituted with aryl(oxy)methyl or benzylamino at position 3; use in combination with antivirals; treating drug resistance infections |
| 03/15/2011 | US7906539 Imidazoles and triazoles, their preparation, and their use as pharmaceutical compositions |
| 03/15/2011 | US7906537 Substituted p-diaminobenzene derivatives |
| 03/15/2011 | US7906536 Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide |
| 03/15/2011 | US7906535 High concentration topical insecticides containing pyrethroids |
| 03/15/2011 | US7906533 Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 03/15/2011 | US7906532 Indazole derivatives |
| 03/15/2011 | US7906531 M3 muscarinic acetylcholine receptor antagonists |
| 03/15/2011 | US7906528 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906522 2-aminoquinazoline derivatives |
| 03/15/2011 | US7906521 Quinazoline potassium channel inhibitors |
| 03/15/2011 | US7906520 Reducing expression of tetrahydrobiopterin (BH4) biological activity; traumatic, metabolic or toxic peripheral nerve lesions |
| 03/15/2011 | US7906519 Methods for concomitant administration of colchicine and a second active agent |
| 03/15/2011 | US7906518 Therapeutic compounds |
| 03/15/2011 | US7906517 Trisubstituted amine compound |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906515 Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation |
| 03/15/2011 | US7906514 Animal model and compounds identified via this model for treatment of chronic pain |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 03/15/2011 | US7906511 Cyclic compound having pyrimidinylalkylthio group |
| 03/15/2011 | US7906510 Amide derivative and pharmaceutical composition containing the same |
| 03/15/2011 | US7906509 Inhibitors of bruton's tyrosine kinase |
| 03/15/2011 | US7906508 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity |
| 03/15/2011 | US7906507 Oxadiazoanthracene compounds for the treatment of diabetes |
| 03/15/2011 | US7906506 Immunomodulators, inducing cytokine biosynthesis in animals; antiviral agents, antitumor agents; e.g. (11S)-1-Methyl-8-propyl-10,11-dihydro-8H-[1,4]oxazino[4',3':1,2]imidazo[4,5-c]quinolin-6-amine |
| 03/15/2011 | US7906505 Apoptosis promoters |
| 03/15/2011 | US7906504 N-tert-Butyl-2-[3-(4-fluoro-3-methoxyphenyl)-1-oxo-7-(3-pyrrolidin-1-ylpropoxy)-1H-isoquinolin-2-yl]acetamide; 2-[3-(3-Chlorophenyl)-7-((S)-2-methyl-3-pyrrolidin-1-ylpropoxy)-1-oxo-1H-isoquinolin-2-yl]-N-isopropylacetamide; antidepressants; hypothalamo-pituitary-adrenal axis modulators |
| 03/15/2011 | US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/15/2011 | US7906502 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/15/2011 | US7906501 Pyrrole derivatives with angiotensin II antagonist activity |
| 03/15/2011 | US7906500 Chalcogenoxanthylium dyes for purging blood pathogens and for photodynamic therapy |
| 03/15/2011 | US7906499 Polycarboxylated porphyrins and use thereof in treatment of metal toxicities |
| 03/15/2011 | US7906498 Cholesterol as an antibiotic for Streptococcus pneumoniae |
| 03/15/2011 | US7906497 Cancer treatment methods |
| 03/15/2011 | US7906495 Monohalogenovinyl vitamin D derivative compounds |
| 03/15/2011 | US7906494 Polymerizable compound and use thereof |
| 03/15/2011 | US7906493 Core 2 GlcNAc-T inhibitors |
| 03/15/2011 | US7906492 Therapy-enhancing glucan |
| 03/15/2011 | US7906491 Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs) |
| 03/15/2011 | US7906490 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders |
| 03/15/2011 | US7906489 18-membered macrocycles and analogs thereof |
| 03/15/2011 | US7906488 Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae |
| 03/15/2011 | US7906487 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide |
| 03/15/2011 | US7906483 Method for treating transplant rejection |
| 03/15/2011 | US7906477 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 03/15/2011 | US7906333 Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same |
| 03/15/2011 | US7906156 CB2 receptors blocks accumulation of human hepatic myofibroblasts: a novel antifibrogenic pathway in the liver |
| 03/15/2011 | US7906154 Compositions and methods for the induction and maintenance of quality sleep |
| 03/15/2011 | US7906153 Mast cells; antiinflammatory agents; multiple sclerosis; central nervous system disorders; mixture of flavonoids and olive extracts |
| 03/15/2011 | US7906150 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium |
| 03/15/2011 | US7906145 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 03/15/2011 | US7906141 Sustained-release, oral pharmaceutical forms of formulation |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | US7906137 Delivery agents for enhancing mucosal absorption of therapeutic agents |
| 03/15/2011 | US7906133 Optimized dosing for drug coated stents |
| 03/15/2011 | US7906128 Controlling parasites in animals by administerinng sodium channel activators |
| 03/15/2011 | US7906126 Adhesive block ethylenic copolymers, cosmetic compositions containing them and cosmetic use of these copolymers |
| 03/15/2011 | US7906109 Pharmaceutical composition comprising an active principal and sulphobetaine |
| 03/15/2011 | US7905724 Methods and systems for concurrent tooth repositioning and substance delivery |
| 03/15/2011 | CA2677910C The use of inhibitors of the renin-angiotensin system for the treatment of cardiovascular diseases |
| 03/15/2011 | CA2675757C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 03/15/2011 | CA2646163C 3,7-diamino-10h-phenothiazine salts and their use |
| 03/15/2011 | CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i |
| 03/15/2011 | CA2619042C Methods and compositions for the prevention and treatment of kidney disease |
| 03/15/2011 | CA2618511C Novel benzothiazolone derivatives |
| 03/15/2011 | CA2613030C Agent for the treatment of herpes virus-derived pain |
| 03/15/2011 | CA2591053C Pyrimidinone compounds and preparation and use thereof |
| 03/15/2011 | CA2566331C Oral delivery system |
| 03/15/2011 | CA2562982C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 03/15/2011 | CA2562897C Immunomodulating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives |
| 03/15/2011 | CA2550660C Florfenicol prodrug having improved water solubility |
| 03/15/2011 | CA2550596C 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 03/15/2011 | CA2528385C A1 adenosine receptor antogonists |
| 03/15/2011 | CA2525772C Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions |
| 03/15/2011 | CA2514114C Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 03/15/2011 | CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 03/15/2011 | CA2502220C Transdermal patch for external use comprising fentanyl |
| 03/15/2011 | CA2499721C Chirale oxazole-arylpropionic acid derivatives and their use as ppar agonists |
| 03/15/2011 | CA2496780C Crystal for oral solid drug and oral solid drug for dysuria treatment containing the same |